{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:27:16Z","timestamp":1782851236593,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,13]]},"DOI":"10.7759\/cureus.23115","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T11:05:22Z","timestamp":1647169522000},"source":"Crossref","is-referenced-by-count":6,"title":["Prediction of Pregnancy Complications With Maternal Biochemical Markers Used in Down Syndrome Screening"],"prefix":"10.7759","author":[{"given":"Savas","family":"Ozdemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuat","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde Zeynep","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Ermin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-2115(00)00431-0","article-title":"Biochemical screening for Down syndrome","volume":"92","author":"Cuckle H","year":"2000","unstructured":"Cuckle H. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol. 2000, 92:97-101. 10.1016\/s0301-2115(00)00431-0","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref2","article-title":"Down syndrome: prenatal risk assessment and diagnosis","volume":"62","author":"Newberger DS","year":"2000","unstructured":"Newberger DS. Down syndrome: prenatal risk assessment and diagnosis. Am Fam Physician. 2000, 62:825-32,837-8.","journal-title":"Am Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone FD","year":"2005","unstructured":"Malone FD, Canick JA, Ball RH, et al.. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005, 353:2001-11. 10.1056\/NEJMoa043693","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2014.936680","article-title":"Screening for Down syndrome","volume":"244","author":"Spencer K","year":"2014","unstructured":"Spencer K. Screening for Down syndrome. Scand J Clin Lab Invest Suppl. 2014, 244:41-7. 10.3109\/00365513.2014.936680","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1002\/pd.2505","article-title":"Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome","volume":"30","author":"Huang T","year":"2010","unstructured":"Huang T, Hoffman B, Meschino W, Kingdom J, Okun N. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn. 2010, 30:471-7.","journal-title":"Prenat Diagn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4141","article-title":"Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications","volume":"33","author":"D'Antonio F","year":"2013","unstructured":"D'Antonio F, Rijo C, Thilaganathan B, Akolekar R, Khalil A, Papageourgiou A, Bhide A. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications. Prenat Diagn. 2013, 33:839-47. 10.1002\/pd.4141","journal-title":"Prenat Diagn"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1251","article-title":"Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler","volume":"25","author":"Spencer K","year":"2005","unstructured":"Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005, 25:949-53. 10.1002\/pd.1251","journal-title":"Prenat Diagn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.12.019","article-title":"First trimester pregnancy-associated plasma protein-A and birth weight","volume":"198","author":"Baer RJ","year":"2016","unstructured":"Baer RJ, Lyell DJ, Norton ME, Currier RJ, Jelliffe-Pawlowski LL. First trimester pregnancy-associated plasma protein-A and birth weight. Eur J Obstet Gynecol Reprod Biol. 2016, 198:1-6. 10.1016\/j.ejogrb.2015.12.019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.09.022","article-title":"Correlation of first-trimester serum levels of pregnancy-associated plasma protein A with small-for-gestational-age neonates and preterm births","volume":"133","author":"Gundu S","year":"2016","unstructured":"Gundu S, Kulkarni M, Gupte S, Gupte A, Gambhir M, Gambhir P. Correlation of first-trimester serum levels of pregnancy-associated plasma protein A with small-for-gestational-age neonates and preterm births. Int J Gynaecol Obstet. 2016, 133:159-63. 10.1016\/j.ijgo.2015.09.022","journal-title":"Int J Gynaecol Obstet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2013.788626","article-title":"First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies","volume":"29","author":"Dane B","year":"2013","unstructured":"Dane B, Dane C, Batmaz G, Ates S, Dansuk R. First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies. Gynecol Endocrinol. 2013, 29:592-5. 10.3109\/09513590.2013.788626","journal-title":"Gynecol Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff L","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, et al.. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). J Obstet Gynaecol Can. 2004, 191:1446-51. 10.1016\/j.ajog.2004.06.052","journal-title":"J Obstet Gynaecol Can"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(02)01655-1","article-title":"Very low second-trimester maternal serum alpha-fetoprotein: association with high birth weight","volume":"99","author":"Baschat AA","year":"2002","unstructured":"Baschat AA, Harman CR, Farid G, Chodirker BN, Evans JA. Very low second-trimester maternal serum alpha-fetoprotein: association with high birth weight. Obstet Gynecol. 2002, 99:531-6. 10.1016\/s0029-7844(02)01655-1","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"Obstetrical complications associated with abnormal maternal serum markers analytes","volume":"30","author":"Gagnon A","year":"2008","unstructured":"Gagnon A, Wilson RD. Obstetrical complications associated with abnormal maternal serum markers analytes. SOGC. 2008, 30:918-32. 10.1016\/S1701-2163(16)32973-5","journal-title":"SOGC"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0223(200008)20:8<652::AID-PD882>3.0.CO;2-6","article-title":"Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome","volume":"20","author":"Spencer K","year":"2000","unstructured":"Spencer K. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenat Diagn. 2000, 20:652-6.","journal-title":"Prenat Diagn"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2012.712572","article-title":"Pregnancy and delivery outcomes following a pathological second trimester triple test screening result and a normal karyotype","volume":"25","author":"Weintraub AY","year":"2012","unstructured":"Weintraub AY, Weiss I, Friger M, Hershkovitz R. Pregnancy and delivery outcomes following a pathological second trimester triple test screening result and a normal karyotype. J Matern Fetal Neonatal Med. 2012, 25:2606-9. 10.3109\/14767058.2012.712572","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)32756-6","article-title":"Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin","volume":"30","author":"Toal M","year":"2008","unstructured":"Toal M, Chaddha V, Windrim R, Kingdom J. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin. J Obstet Gynaecol Can. 2008, 30:198-206. 10.1016\/S1701-2163(16)32756-6","journal-title":"J Obstet Gynaecol Can"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-03298-9","article-title":"Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study","volume":"20","author":"Boonpiam R","year":"2020","unstructured":"Boonpiam R, Wanapirak C, Sirichotiyakul S, Sekararithi R, Traisrisilp K, Tongsong T. Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study. BMC Pregnancy Childbirth. 2020, 20:621. 10.1186\/s12884-020-03298-9","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.03.011","article-title":"Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin","volume":"194","author":"Towner D","year":"2006","unstructured":"Towner D, Gandhi S, El Kady D. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. Am J Obstet Gynecol. 2006, 194:1676-82. 10.1016\/j.ajog.2006.03.011","journal-title":"Am J Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1067\/s0002-9378(03)00769-5","article-title":"Unexplained elevated maternal serum alpha-fetoprotein and\/or human chorionic gonadotropin and the risk of adverse outcomes","volume":"189","author":"Chandra S","year":"2003","unstructured":"Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M. Unexplained elevated maternal serum alpha-fetoprotein and\/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol. 2003, 189:775-81. 10.1067\/s0002-9378(03)00769-5","journal-title":"Am J Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2011.63","article-title":"Effect of maternal weight on postterm delivery","volume":"32","author":"Halloran DR","year":"2012","unstructured":"Halloran DR, Cheng YW, Wall TC, Macones GA, Caughey AB. Effect of maternal weight on postterm delivery. J Perinatol. 2012, 32:85-90. 10.1038\/jp.2011.63","journal-title":"J Perinatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87817-prediction-of-pregnancy-complications-with-maternal-biochemical-markers-used-in-down-syndrome-screening","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:01:33Z","timestamp":1726808493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87817-prediction-of-pregnancy-complications-with-maternal-biochemical-markers-used-in-down-syndrome-screening"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.23115","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,13]]}}}